AIM · AIM ImmunoTech Inc. · Exempt Offerings
$0.19
+0.01 (+5.56%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has incurred losses from operations and operating cash outflows exceeded cash inflows from operating activities for the six months ended June 30, 2026. These conditions raise substantial doubt regarding the Company's ability to continue as a going concern for a period of at least one year from the date of issuance of these consolidated financial statements.”View the 10-Q filed Aug 7, 2026
Market Cap
$5.58M
Shares
30.44M
Volume · Oct 5
1.13M
Avg daily vol (3M)
4.64M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.